International Conference on Oncolytic Virus Therapeutics(ICOVT) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Oncolytic Viruses and Immunotherapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Oncolytic Viruses and Immunotherapy. Oncolytic Virus is an international platform for presenting research about Virus Outbreaks, control and Therapy. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Oncolytic viruses are a novel class of anti-cancer agents which in many cases have entered clinical trials. These viruses are capable of attacking cancer cells in a distinctive manner leading to cell-specific and targeted tumor therapy.

Read on conferenceonline.net

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options, Current and evolving paradigms in precision oncology approach for management of common malignancies and Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.

Read on: education.binayfoundation.org

Over the past 11 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology. CHI’s IO Summit provides access to a comprehensive 3-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies, appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance.

Every year, we assemble an international mix of thought-leaders and decision-makers from industry and academia to bring you the latest developments in immuno-oncology, so that, together, we continue to align as a formidable force against cancer. Additionally, the progressive venue provides extensive networking and collaborative opportunities to enable teams to focus on their goals as they advance our understanding of the immune system to provide next-generation immunotherapies to all patients.

Read on immuno-oncologysummit.com

Oncologists across the U.S. are preparing for increased patients seeking treatment for more advanced-stage cancers than in the past. Clinicians and researchers are also redesigning the cancer patient journey and developing more sophisticated therapies that are revolutionizing what it means to treat cancer today. Join us for this virtual event and hear insights from top oncology leaders about where the field is today, and where it's headed. 

Read on events.beckershospitalreview.com

Discover effective strategies for oncology trial operations to ensure trials run smoothly and within budget. Arena International is delighted to announce Clinical Operations in Oncology Trials East will take place in Boston in July 2023! Bringing together clinical operations experts from oncology pharma and biotech sponsor companies on the East Coast alongside technology vendors, CROs and patient advocates, this will provide a perfect platform to uncover new technologies, processes and solutions to operational challenges when running an oncology trial. The programme will look at the latest challenges and innovations in oncology operations including fostering relationships with clinical sites, innovating data management processes and navigating new regulations impacting oncology trials in the US. Featuring a brand new track on Clinical Technology and Innovation, the conference will be the platform for innovative case studies and break out discussions to connect and enhance your knowledge in the oncology space. Clinical Operations in Oncology is the meeting place for leading pharmaceutical companies and biotechnology institutes. Discover how to excel in oncology operations and clinical supply strategy as well as form key connections for long-term success for your clinical trial. Join us for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management.
Read on arena-international.com

The 2023 Gordon Research Seminar on Cancer Nanotechnology (GRS) will be held in Waterville Valley, NH. The Cancer Nanotechnology GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators. The third Gordon Research Seminar on Cancer Nanotechnology will bridge nanotechnology research with translational pre-clinical cancer research. Graduate students, post-docs, and other early-career scientists will have the chance to present their cutting-edge ideas and unpublished data, as well as network with peers in an engaging environment. Nanotechnology offers exciting opportunities in the battle against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. The 2023 GRS will provide an overview of emerging cancer-related nanotechnologies from the bench to the bedside. By bringing together exceptional scientists representing clinical, biological, and physical sciences, we will gain new insights into the interface of bio-nano science and cancer nanotechnology.

Read on:grc.org/cancer-nanotechnology-grs

The Cancer Genetics and Epigenetics GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. The 2023 Conference on Cancer Genetics and Epigenetics will highlight the new development, challenges and opportunities in precision cancer medicine. The conference will focus on emerging technologies and analytical computational methods deciphering mechanistic insights from the studies of individual cancer genome and epigenome leading to drug discoveries and novel precision therapeutics. Heterogeneity of cancer and evolutionary trajectory of cancer will be explored in the context of genetics, epigenetics as well as genome topology, enabled by modern technologies including single cell genomics and CRISPR-based genome and epigenome engineering tools amenable to studies in tumor samples. An emphasis will be put on the emerging roles of non-coding genome and epi-transcriptome in cancer, and how they inform novel therapeutic strategies. Challenges in designing future generation cancer genomics studies and integrating large cancer genomics data will be addressed. This meeting should appeal to a wide range of cancer researchers, molecular biologists, and bioinformaticians seeking to apply the latest genetics and epigenetics discoveries to their work to cancer. In addition to an outstanding set of invited speakers there will be several interactive poster sessions, one minute "poster preview" talks and several talks selected for platform presentation from the submitted abstracts.

Read on grc.org

The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.  For 2023, we have revamped and repositioned the schedule to reflect the dynamic research environment of the cell therapy field.  Enjoy an exclusive pre-event evening networking session centred around overcoming barriers to patient access and facilitating clinical distribution of transformative cell therapy products. 

Our on-stage talks, panels and Q&As will come under the following themes:  

• Breakthroughs and Pipeline Advancements 
• New Cell Therapy Platforms and Enabling Technologies 
• Manufacturing at Scale and Commercialization 
• Pre-event evening expanding into Cell Therapy Access 

Read on oncocelltherapy.com

s clinical research in the oncology therapeutic area becomes increasingly complex, effectively capturing high-quality data across multiple endpoints becomes even more critical to a drug’s success. Many oncologic agents have cardiac toxicities, including depression of left ventricular function, QTc prolongation and elevation of blood pressure. Register for this webinar to learn about the intersection of oncology drug development and cardiac safety, and how this new area is changing the landscape for early-phase clinical trials. Cardio-oncology, an evolving subspecialty focused specifically on the detection and management of these risks, has become an essential consideration within any oncology development program. Additionally, with the growing emphasis on patient-focused drug development, recent regulatory guidelines now outline core patient-reported outcomes (PROs) that should be included in oncology clinical trials. Among these are self-reported symptomatic adverse events, with the new 2023 US Food and Drug Administration (FDA) draft guidance acknowledging the importance of utilizing this self-reported data to enhance the assessment of tolerability in early-phase dose optimization trials.

Read on xtalks.com

All healthcare professionals with an interest in cancer care from all specialties and disciplines including physicians, oncology nurse practitioners, physician assistant genetic counselors, scientists, pharmacists, nurses, and other allied healthcare professionals.

As a result of participating in this activity, participants should be able to:

• compare the latest advances in the field of precision oncology, especially in testing approaches.
• discuss the application of these advances in patient care.
• analyze real-world experiences and case studies of integrating precision medicine into clinical practice.

Read on eventbrite.com

The conference has been carefully curated to meet the outstanding standards of our attendees and thus provides an excellent platform for interactive congregations of knowledge and wisdom about path-breaking research on Clinical Oncology and Pharmacology around the world. We aim to encourage the progress of efforts to explain the untapped medicine behind the mystery of oncology applications, their mechanisms, fabrication, integration of cancer therapy, and management, including an active conversation of novel drugs about recent advances in the field of pharmacology.

Read on clinicaloncology.alliedacademies.com

Oncology is a dynamic field with rapidly evolving technology and treatment pathways to improve the lives of cancer patients and survivors. Precision medicine, genomics and novel therapies are revolutionizing cancer care and hold great promise for the future. Healthcare stakeholders are also focused on expanding access to cancer care and achieving health equity for underserved communities. Join us for this virtual event and hear insights from top oncology leaders about where the field is today, and what to expect in the next few years.

Read on events.beckershospitalreview.com

International Conference on Clinical and Medical Oncology 2023 is going to be held in London, UK on August 10-11, 2023. Oncology Conferences create a new platform to discuss and share all the advancements in the field of Clinical and Medical Oncology

Read on oncology.euroscicon.com

The American Cancer Society estimates there are currently 16 million Americans who are cancer survivors. Because of improved detection and treatment, nearly 70% of patients with a cancer diagnosis will go on to live their full life expectancy. Cancer treatments however are not without peril as the side effects of surgery; chemotherapy and radiotherapy have a deleterious impact on function in a majority of patients. These side effects may occur in both the short and long term and many persist over the remaining lifetime of the patient. With escalating numbers of survivors, we also see escalating functional limitations and disability in the survivorship population necessitating a greater focus on cancer by the rehabilitation community.

Asynchronous portion will be delivered in short video modules that will be in total duration of 180 minutes and will include the following content: Cancer Epidemiology, Tumor pathology, growth & histology, Disease diagnosis & staging, Disease treatment: surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapies. To be viewed prior to synchronous virtual course.

Read on eventbrite.com

During the registration process delegates will be asked to indicate on-site or online participation.  N.B. On-site participation also includes access to the online platform. Individual registration will remain open for the duration of the meeting. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

Read on esmo.org

LUMIMINDS CONVENTIONS is glad to announce our upcoming International Conference on Oncology and Radiology – ICOR 2022 that will be held Online during December 07-08, 2022. The theme of the conference is “Upcoming technologies that revolutionize the future of cancer treatment”. We take great pleasure in inviting all the Academicians, Scientists, Young Researchers and Students, Oncologists, Radiologists, Cancer therapists, Radiation Oncologists, Clinical Professionals, and Business professionals pertaining to across the world for our upcoming ICOR 2022 to witness and participate in highly professional scientific discussions and sessions. ICOR 2022 will have Invited Talks/Keynote Talks, Scientific Sessions, Workshops, Poster Presentations, Networking Sessions, etc. As part of encouraging young researchers, we have a special session, the Young Scientist Session. Hope you all join and make the most exciting event of the year successful. You are assured of discovering the latest developments and breakthroughs that are exclusive to your field of work with its scientific sessions.

Read on lumiminds.org

Most of all, AAC extends its warm greetings to all Organizing Committee Members, Keynote Speakers, Speakers, Delegates, Exhibitors and students who were a part of Pathology and Oncology Research 2022 and making it a grand success. Allied Academics hosted the joint event of “4th International Conference on Pathology and Oncology Research” which was held during November 28-29, 2022 with the theme “Navigating the future on Pathology and Oncology”. The active support of the Editorial Board Members, Scientists, Researchers, Scholars, and Students in the field of Pathology are the backbone of the conference success.

Read on europathology.alliedacademies.com

Radiation oncology (radiotherapy/radiation therapy) is a medical speciality this is an essential a part of a multidisciplinary method to cancer treatment. It uses excessive electricity x rays(photons) most commonly introduced through a linear accelerator. Diation oncology (radiotherapy/radiation remedy) is a clinical speciality that is an critical a part of a multidisciplinary method to cancer remedy. It uses excessive electricity x rays(photons) most typically added thru a linear accelerator. These therapeutic x rays are painless and invisible and are used to deal with some of distinct cancers. The linear accelerator is housed within a cancer centre and a multidisciplinary crew comprising of radiation oncologists (your professional medical doctor), nurses, radiation therapists and medical physicists will communicate to you about radiation remedy as a treatment alternative, assess you, plan and deliver your treatment as well as help you with any side effects you revel in.

Read on radiationoncology.conferenceseries.com

On behalf of the members of the Organizing Committee, we are honored to welcome you  to the 2nd International Conference on Oncology which is going to be slated on  November 22-23, 2022 in Dublin, Ireland with theme “Novel research and advancement in the field of Oncology Research”. International Conference on oncology 2022 will focus on many interesting scientific sessions and covers all frontier topics in oncology which include Cancer Epidemiology, Cancer Pharmacology, Clinical Oncology ,Cancer Cell Biology & Genetics, Breast Cancer, Pediatric Cancer, Cancer and Stem Cell Therapy, Anti-Cancer Drugs, Cancer Treatments & Rejuvenation, Neuroradiology and Neuro Oncology, Gynaecological Cancers, Hematological Cancers, Radiation Oncology ,Tumor Virology, Immunology and Cellular Pathology Cancer, Biomarkers.

Read on oncology.alliedacademies.com

Providing a comprehensive program on the latest innovations in cancer treatments and research, Oncology Convention is open to all UK-based medical oncologists and their wider senior management teams. The event will focus on the four main cancers: lung, prostate, colorectal and breast. Roar B2B is a visionary events company that puts people at the centre of today’s most topical, growing and engaged industry sectors. With offices in London and Bristol, we’re dedicated to delivering sustainable sector-leading events which bring people together to build content, customer-centric community and conversation.

Read on oncologyconvention.com

We are delighted to extend an invitation on behalf of the Scientific Committee to the 6th Global Meeting on Oncology and Radiology, which will be held in Madrid, Spain on November 07-08, 2022. "Insight into the advances in Radiology & Oncology" is the theme of the Radiology and Oncology 2022 conference, which includes a wide range of vitally important sessions in the fields of Oncology, Radiology, Cancer, and Imaging. All elements of cancer imaging and intervention will be covered in this interdisciplinary multi-specialty oncology course. The goal of this gathering is to provide the most up-to-date information on radiology as well as innovative cancer treatment alternatives. We will bring together academics and young scientists from all around the world.

Read on radiology-oncology.annualcongress.com

Conference Series LLC LTD is an international online Open Access platform. Which organize a series of 3000+ International Events with 1000+ international conferences every year across USA, Europe, & Asia. We would like to acknowledge you about 3rd International Conference on Clinical Oncology & Radiation Therapy (Oncology and Radiology 2022) which is going to be held on October 27-28, 2022 in Amsterdam, Netherlands. Oncology and Radiology 2022 make up with a mission to extend over a wide area and distribute the quality research by the oncologist. Our conference connects internationally prominent speakers and scientists to create engrossing and memorable events, filled with lively interactive sessions and world-class exhibitions and poster presentations. Oncology and Radiology 2022, which will be a prevalent platform for all the Healthcare Leaders coming from different parts of countries to show their success and discuss on the imminent scope and development of Oncology and Radiation Therapy. The Oncology and Radiology 2022 is to create a better knowledge sharing platform for the all Oncologist, students, and industry participants coming from all around the world. We are sure that the Oncology and Radiology 2022 will be edifying and also will uplift delegates to share their research views with fellow participants.

Read on oncology.insightconferences.com

For patients with advanced cancer, services such as palliative care, psycho-oncology, and integrative oncology can address many common symptoms and improve quality of life. Even though these services improve outcomes, access to them is limited in many health systems. In this Master Clinician session, Drs. Stephanie Cheng and Neha G. Goyal will describe how telehealth group medical visits (“group visits”) are a potential answer to expand access to these services. Group visits combine medical care, health education, and peer support.

Read on capc.org

Northwell Health's annual Oncology Conference will focus on transitions in cancer care, including care of the young adult patient. You are now directed to a third-party registration site, Eventbrite. Please note that Eventbrite is a third-party information portal that is not owned, operated, or managed by Northwell Health. Your use of Eventbrite is solely at your discretion and is governed by Eventbrite's Privacy Notice and Terms of Service. Northwell Health does not make any representation or warranties of any kind, express or implied, with respect to the contents or operation of this website.

Read on eventbrite.com

At MAP 2022, international key opinion leaders will explain how to use genomic data for treating cancer patients, matching such data to a specific drug or therapy, based on the genetic drivers detected in the patients’ tumours, and they will debate about the future challenges in precision oncology.

Read on esmo.org

The landscape of cancer care is rapidly evolving and oncology pathways play a critical role in defining how we treat our patients. We are excited to be back in Boston for an informative and substantive three-day program. As the official congress of the Journal of Clinical Pathways, this meeting serves as a forum for those involved in all stages of the pathway development to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs. The Oncology Clinical Pathways Congress is a one-of-a-kind opportunity for all of those in cancer care to gather together and make a positive impact on the future of patient care.

Read on clinicalpathwayscongress.oncnet.com

Over the past 10 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.

Read on immuno-oncologysummit.com

The 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2022 ASCO Annual Meeting in June 2022. This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:

• Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
• Current and evolving paradigms in precision oncology approach for management of common malignancies.
• Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.

Read on education.binayfoundation.org

The NHS Oncology Conference provides a high-value and peers focused platform for NHS Oncology and Cancer specialists to share practical insights and best practices from across the UK. Our physical events offer a unique opportunity to meet with key sector stakeholders in an informal and relaxed atmosphere, this provides an ideal chance to discuss strategic change and learn from some of the most well-respected public sector professionals in the country, all while soaking up the lovely atmosphere our venues and audience provide.

The Covid pandemic caused a sharp increase in waiting times and backlogs in a healthcare system that was already operating extremely close to its maximum capacity. By September 2021, it’s estimated there were 5.83 million patients on the waiting list for elective care, 1.95 million of those patients had been waiting for more than 18 weeks, including 301,000 waiting for more than a year. To try and reduce further crisis NHS England set up a national Cancer Recovery Taskforce, headed up by Professor Peter Johnson, National Clinical Director for Cancer, and includes representatives from cancer charities, royal colleges, national teams and the NHS Cancer Programme’s Patient and Public Voices (PPV) Forum.

Read on convenzis.co.uk

Building on the excellent experience in the past 2 years offering virtual Congresses due to COVID-19, the Board intends that the 2022 SIOP Congress will be the Society’s first hybrid Congress, offering some sessions for access virtually. Despite the early signs that the COVID-19 pandemic can be brought under control, access to vaccination is not yet equitable across the world and the emergence of viral variants continues to impose travel restrictions and workforce pressures. For these reasons, we will make best efforts to offer the 2022 Congress as a hybrid event. We have all learnt new ways to interact and network during the past year. The SIOP 2022 congress will be the place to hear the latest research findings in our field and to catalyse new ideas, generated by the multi-disciplinary attendance for which we are renowned. Furthermore, the pre-Congress Educational Day, with parallel sessions organised by the Local Organising Committee, the Young SIOP Network, Nursing Network, Paediatric Psycho-oncology Network and the Global Health Network provides an excellent forum to meet with your peers and hear about opportunities for networking and collaboration. Dr. Lillian Sung, who leads the SIOP Scientific Committee, has prepared an innovative Programme of exceptional speakers and symposium topics that will appeal to you all.

Read on siop-congress.org

This is the must-attend symposium for those looking to learn efficient, innovative applications to significantly improve the lives of patients with cancer. Spend a weekend with experts in Miami Beach and leave equipped with powerful new ideas and techniques you can immediately implement into your practice. CIO offers real-world education through practical IO presentations, hands-on workshops, case review with the experts, and lessons learned from complications and saves.

Read on theiomeeting.com

Learn how to effectively manage patients with dental oncology needs. Dentists and members of dental teams play a crucial role in the management of oncology patients. This presentation will focus on identification and treatment/prevention of common oral complications of cancer therapy with a focus on complications of chemotherapy and hematopoietic cell transplantation including oral mucositis, oral infections, salivary gland dysfunction, medication-related osteonecrosis of the jaw, and emerging complications of immunotherapies.

Read on eventbrite.com

The shared mission of the Canadian Association of Psychosocial Oncology (CAPO) and the International Psycho-Oncology Society (IPOS) is to foster the science and practice of psychosocial oncology to improve the care for people affected by cancer through partnerships, research, public policy, advocacy and education. Our 2022 World Congress will create an opportunity to bring together an international body of health care professionals. This forum encourages new global partnerships and allows for the dissemination of ground-breaking research to professionals and the general public about psycho-oncology, that is, the psychosocial (psychiatric, psychological, social, behavioural, ethical) and psychobiological aspects of oncology. Finally, this forum allows us to recognize exceptional contributions from around the world to the field of psycho-oncology through our awards of excellence.

Read on capo.ca

The theme of the Webinar focuses on "Exploring the research ideas in Oncology and Cancer Research".  We aim to bring together experts from relevant fields, regulatory bodies and research institutions to exchange ideas, build up networksand work collaboratively. Oncology 2022 will provide an unparalleled opportunity to network with leading academicians, practitioners and business professionals from around the world to share the most significant advances and concerns in the field of cancer research. Oncology 2022 will be held  online allowing us to provide a unique experience for all delegates regardless of the mode of participation allowing many more people to participate. Cancer Research features a comprehensive scientific program spanning a wide range of topics including Recent Research in Cancer Research, Medical Oncology, Surgical Oncology, Radiation Oncology, Breast Cancer, Carcinoma, Lymphoma, Leukemia,Cancer Treatment and Preventive measures for information exchange and to harness this momentum of change to implement a new future shaped in the image of human needs.

Read on meetingsint.com

This important educational activity will provide guidance to front-line and oncology clinicians, nurses, nurse practitioners, physician assistants and pharmacists with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies.

Read on meetingsint.com

Oncologists across the U.S. are preparing for increased patients seeking treatment for more advanced-stage cancers than in the past. Clinicians and researchers are also redesigning the cancer patient journey and developing more sophisticated therapies that are revolutionizing what it means to treat cancer today. Join us for this virtual event and hear insights from top oncology leaders about where the field is today, and where it's headed.

Read on events.beckershospitalreview.com

After two years of a fully online event, we’re excited to be back in Liverpool with a refreshed congress. As always the event will offer three days of education and CPD with a programme that showcases the most cutting-edge content for a multidisciplinary audience that addresses the medical, scientific, educational and management issues in the diverse fields of diagnostic imaging, oncology, and radiological sciences. Alongside this is a large professional exhibition of the latest state-of-the-art equipment, services and technology available in the industry.

Read on ukio.org.uk

Join us at The NHS Oncology Conference 2022 Manchester as we explore these new areas of best practice, network with peers and share insights across a short but high-value conference. Research sources for The NHS Oncology Conference 2022 Manchester: NHS England and improvement, Cancer Research UK. At Convenzis we pride ourselves on our ability to develop, manage, and host both virtual and physical events for the public and commercial sectors. Our physical events offer a unique opportunity to meet with key sector stakeholders in an informal and relaxed atmosphere, this provides an ideal chance to discuss strategic change and learn from some of the most well-respected public sector professionals in the country, all while soaking up the lovely atmosphere our venues and audience provide.

Read on convenzis.co.uk

Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown faculty, and connect with one of the largest, most diverse audiences in global oncology – in person or online.

Advancing Equitable Cancer Care Through Innovation

By innovating across boundaries, we can bring down barriers to access and make care more equitable, convenient, and efficient for patients worldwide. 

Read on conferences.asco.org

Due to the pandemic, the #Sachs_IOIF event will be once again hosted in a digital format. This will allow us to further support our community and past attendees, bridging Europe and the US. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system. The programme for the 8th Annual IOIF will be spread throughout 2 days. Featuring more than 12 hours of keynotes, high-level speeches, panel discussions and spotlight showcases by leading corporates. The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharma’s and biotech’s.
 
We anticipate over 300 delegates and 20+ company presentations by established listed, private and emerging companies. Over half of these attendees are corporate and financial investors, analysts, bankers and advisors. The forum is highly transactional and based on past events we anticipate a high level of activity on the Online Meeting System, which will be open the whole week of the conference, from 23rd to 27th of May.

Read on sachsforum.com

The joint International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) and the European Congress on Head and Neck Oncology (ECHNO) is taking place in Brussels, Belgium and Online from 3 to 5 March 2022. For those of you who might still be facing travel restrictions in advance of the conference, we are putting in place the option to participate virtually to the congress, thanks to an online platform, where sessions in digital format will be made available for both onsite and online attendees.

The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the pleasure to invite you to participate in this congress. This joint congress promises to provide a unique platform for the dissemination of the most relevant and cutting-edge science and innovation in the field of head and neck oncology. ICHNO and ECHNO, biannual congresses respectively, promote multidisciplinarity in head and neck oncology.

Read on estro.org

The Convenzis Oncology Virtual Conference series aims to provide a secure and focused environment for NHS cancer specialists to listen, learn and engage with peers and sector leaders from across the UK and further afield. 

Read on convenzis.co.uk

This Oncology and Radiology 2021 will focus on the theme “Progression and Innovation in Radiology & Oncology”.

PMLS Virtual Series 2021 - Precision Oncology Fall To Register Click Here Oct 5, 2021 Precision Oncology had a tremendous boost with the 2015 roll-out of the Precision Medicine Initiative.  

Read on precisionmedicineleaderssummit.com

The CE conference is devoted to providing the latest developments in multidisciplinary treatment, practical patient management, and interprofessional care of oncology patients.

ASCO Direct™ Highlights: 2021 Official Annual Meeting Review, an officially licensed program of the American Society of Clinical Oncology® (ASCO®) is the 9th annual conference being organized by the Binaytara Foundation and features some of the most well-known experts in the field of hematology and oncology. 

Join at 7th Edition of International Conference on Clinical and Medical Oncology Conferences and webinars schedule during March 22-23, 2021 in Barcelona, Spain. Oncology 2021 brings upon a new platform to discuss and share all the advancements.

Read on oncology.euroscicon.com

This year, we’re focused on a critical safe path forward, so you can still access groundbreaking science in oncology, the latest trends in clinical application and treatment, and insights on equitable cancer care. The 2021 ASCO Annual Meeting will be online-only – both scientific and education programs occurring June 4-8.

With members from around the world focused on learning about Tumor and Cancer immunology and its advances: this is your best opportunity to reach the largest assemblage of participants from the Tumor & Cancer immunology community. conduct presentations, distribute information’s, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event, world-renowned speakers, the most recent techniques, developments, and the newest updates in Tumor & Cancer immunology are hallmarks of this conference.

Read on cancerimmunology.conferenceseries.com

The current health crisis due to COVID-19 has transformed and changed how care is being delivered in Medical and Radiation Oncology areas across the US. Rapid adoption of TeleHealth by three fold, combined with Virtual Care has enabled collaborative decision-making and innovative ways to support vulnerable groups. This summit aims to:

• Bring providers, commercial payors and CMS together for a one-day summit
• Discuss challenges: practice changes, virtual care & impact to quality of care
• Debate on the policy changes and impact across the US health system